These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17114841)

  • 21. Propofol treatment of refractory status epilepticus: a study of 31 episodes.
    Rossetti AO; Reichhart MD; Schaller MD; Despland PA; Bogousslavsky J
    Epilepsia; 2004 Jul; 45(7):757-63. PubMed ID: 15230698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propofol and midazolam in the treatment of refractory status epilepticus.
    Prasad A; Worrall BB; Bertram EH; Bleck TP
    Epilepsia; 2001 Mar; 42(3):380-6. PubMed ID: 11442156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Status epilepticus: emergency management.
    Singhi S; Singhi P; Dass R
    Indian J Pediatr; 2003 Mar; 70 Suppl 1():S17-22. PubMed ID: 12785277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
    Dubey D; Bhoi SK; Kalita J; Misra UK
    Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of refractory status epilepticus in adults: still more questions than answers.
    Rossetti AO; Lowenstein DH
    Lancet Neurol; 2011 Oct; 10(10):922-30. PubMed ID: 21939901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of refractory status epilepticus at a tertiary care centre in a developing country.
    Tripathi M; Vibha D; Choudhary N; Prasad K; Srivastava MV; Bhatia R; Chandra SP
    Seizure; 2010 Mar; 19(2):109-11. PubMed ID: 20034814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of severe refractory status epilepticus in children.
    Sahin M; Menache CC; Holmes GL; Riviello JJ
    Epilepsia; 2001 Nov; 42(11):1461-7. PubMed ID: 11879350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of status epilepticus: a survey of neurologists.
    Claassen J; Hirsch LJ; Mayer SA
    J Neurol Sci; 2003 Jul; 211(1-2):37-41. PubMed ID: 12767495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic.
    Reddy DS
    J Pharmacol Exp Ther; 2024 Jan; 388(2):273-300. PubMed ID: 37977814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors affecting mortality of refractory status epilepticus.
    Tatlidil I; Ture HS; Akhan G
    Acta Neurol Scand; 2020 Feb; 141(2):123-131. PubMed ID: 31550052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
    Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
    Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit.
    Holtkamp M; Othman J; Buchheim K; Meierkord H
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):534-9. PubMed ID: 15774441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus.
    Claassen J; Hirsch LJ; Emerson RG; Bates JE; Thompson TB; Mayer SA
    Neurology; 2001 Sep; 57(6):1036-42. PubMed ID: 11571331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refractory status epilepticus: frequency, risk factors, and impact on outcome.
    Mayer SA; Claassen J; Lokin J; Mendelsohn F; Dennis LJ; Fitzsimmons BF
    Arch Neurol; 2002 Feb; 59(2):205-10. PubMed ID: 11843690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Refractory status epilepticus in children: characterisation of epilepsies, continuous electroencephalographic monitoring and response to treatment].
    Cardoso I; Acevedo K; Hernández M; Santin J; Moya P; Godoy J; Castillo A; Soto P; Mesa T
    Rev Neurol; 2013 Apr; 56(8):401-8. PubMed ID: 23568682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants and predictors of outcome in super refractory status epilepticus--a developing country perspective.
    Jayalakshmi S; Ruikar D; Vooturi S; Alladi S; Sahu S; Kaul S; Mohandas S
    Epilepsy Res; 2014 Nov; 108(9):1609-17. PubMed ID: 25246354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of status epilepticus].
    Tsuji S; Akamatsu N
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1097-9. PubMed ID: 12235807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus.
    Rao SK; Mahulikar A; Ibrahim M; Shah A; Seraji-Bozorgzad N; Mohamed W
    Epileptic Disord; 2018 Aug; 20(4):265-269. PubMed ID: 30113012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical profile and outcome of refractory convulsive status epilepticus in older children from a developing country.
    Lingappa L; Konanki R; Patel R; Vooturi S; Jayalakshmi S
    Seizure; 2016 Mar; 36():31-35. PubMed ID: 26889778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience.
    Grosso S; Zamponi N; Bartocci A; Cesaroni E; Cappanera S; Di Bartolo R; Balestri P
    Eur J Paediatr Neurol; 2014 Sep; 18(5):604-8. PubMed ID: 24836405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.